Medicared For All Logo

Jaime Catala in Delray Beach, Florida

Home Florida Delray Beach

Jaime Catala has Infectious Disease as his primary medical specialty. Their primary office is: 5130 Linton Blvd in Delray Beach, Florida. There is an additional office location, for a total of two, for Jaime Catala that can be viewed further down.

They're a part of the: Mohamed Erritouni Md Inc medical group which has around 3 members. You can call their office at 561-501-4266 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2009 (around 15 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Jaime Agustin Catala Office Phone and Directions

Jaime Catala
Mohamed Erritouni Md Inc
5130 Linton Blvd
Delray Beach, Florida 33484
561-501-4266


Patient Ratings
Please rate your experience with Jaime Catala below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 561-501-4266


Enter a starting address:


Healthcare Info for Jaime Catala

Medical School: Sorry, his university is not listed
Graduation Year: 2009
The Primary Medical Specialty for Jaime Catala is listed as: Infectious Disease
Approximate Years of Experience: 15
PAC (PECOS ID)#: 2769613314
NPI #: 1104257211
NPI Created On: 11/29/2013
NPI Last Updated Listed as: 07/20/2021
Primary Taxonomy Code: 207RI0200X
License Number:
ME140588
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  3. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  4. New patient office or other outpatient visit, typically 45 minutes
  5. Established patient office or other outpatient visit, typically 15 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Hospital observation care, typically 70 minutes
  9. Initial hospital inpatient care, typically 70 minutes per day
  10. Subsequent hospital inpatient care, typically 25 minutes per day
  11. Subsequent hospital inpatient care, typically 35 minutes per day
  12. Physician telephone patient service, 11-20 minutes of medical discussion
  13. Physician telephone patient service, 21-30 minutes of medical discussion
  14. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
  15. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
  16. Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem
  17. Injection, ceftriaxone sodium, per 250 mg
  18. Injection, daptomycin, 1 mg
  19. Injection, ertapenem sodium, 500 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813494931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813494935

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813494939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794225457

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794225453

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: TEFLARO

Open Associated Drug #1: 0456-0600-10


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794225455

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 844883783

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Antibiotic

Name of Drug #1: Xenleta

Open Associated Drug #1: 72000-120-06

Drug or Biological: Drug

Product Category #2: Oxazolidinone antibiotics

Name Of Drug #2:: Sivextro

Associated Drug #2: 67919-040-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848410295

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: DIFICID

Open Associated Drug #1: 52015-080-01

Drug or Biological: Drug

Product Category #2: INFECTIOUS DISEASE

Name Of Drug #2:: ZINPLAVA

Associated Drug #2: 0006-3025-00


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848410397

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: DIFICID

Open Associated Drug #1: 52015-080-01

Drug or Biological: Drug

Product Category #2: INFECTIOUS DISEASE

Name Of Drug #2:: RECARBRIO

Associated Drug #2: 0006-3856-02

Drug or Biological #3:: Biological

Product Category #3: INFECTIOUS DISEASE

Name of Drug: ZINPLAVA

Name Of Drug #3: 0006-3025-00


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848410813

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: DIFICID

Open Associated Drug #1: 52015-080-01


Additional Office Locations

1. Huna Med Inc
5130 Linton Blvd
Delray Beach, FL 33484
Suite G6
Group Members: 2


Enter a starting address:


Infectious Disease Professionals in Delray Beach

6238 W Atlantic Ave
Delray-beach, FL
Indira Marmolejos Md Pa

6238 W Atlantic Ave
Delray-beach, FL
Indira Marmolejos Md Pa

5130 Linton Blvd
Delray-beach, FL
Mohamed Erritouni Md Inc

5352 Linton Blvd
Delray-beach, FL
Christopher D. Cortes, Md, Inc.

5130 Linton Blvd
Delray-beach, FL
Christopher D. Cortes, Md, Inc.

13550 Jog Rd
Delray-beach, FL

Providers in Mohamed Erritouni Md Inc

1.Jaime Catala

5130 Linton Blvd
Delray Beach Fl 33484-6597
Mohamed Erritouni Md Inc
Infectious Disease

2.Mohamed Erritouni

5130 Linton Blvd
Delray Beach Fl 33484-6597
Mohamed Erritouni Md Inc
Infectious Disease

3.Eric Raguindin

5130 Linton Blvd
Delray Beach Fl 33484-6597
Mohamed Erritouni Md Inc
Nurse Practitioner

View all 3 members of Mohamed Erritouni Md Inc medical group